Our CEO Kon­stan­ti­nos Antonopou­los pre­sent­ed mk2 Biotech­nolo­gies on this year’s Chem­Spec Europe in Basel to the wider fine and spe­cial­ty chem­istry audi­ence. The response to our alter­na­tive options to con­ven­tion­al active chem­i­cals was sig­nif­i­cant and stim­u­lat­ed sev­er­al fruit­ful dis­cus­sions.

Sup­port and pho­to­graph­ic mate­r­i­al by BCNP Con­sul­tants is acknowl­edged.